The Ensign Group, Inc. (ENSG) Guidance & Earnings Results

On 2026-07-27 The Ensign Group, Inc. raised guidance: "FY2026 EPS guidance raised to $7.75-$7.85 from $7.48-$7.62; revenue raised to $5.87B-$5.92B from…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ENSGThe Ensign Group, Inc.Follow ENSG — free

Medical Care Facilities · Healthcare

—

Price chart with a free account

Market cap: 10.2B
P/E TTM: 27.5
Dividend yield: 0.1%
52-week: —
Next earnings: 3 Nov, in 10 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
27 Jul 26	Raised	FY2026 EPS guidance raised to $7.75-$7.85 from $7.48-$7.62; revenue raised to $5.87B-$5.92B from $5.81B-$5.86B. · full year
30 Apr 26	Raised	Raises 2026 Annual Earnings and Revenue Guidance · full year
4 Feb 26	Raised	FY2026 EPS guidance $7.41-$7.61, revenue $5.77B-$5.84B · full year
3 Nov 25	Raised	EPS guidance raised to $6.48-$6.54 from $6.34-$6.46; revenue guidance raised to $5.05B-$5.07B from $4.99B-$5.02B · full year
24 Jul 25	Raised	FY2025 EPS guidance raised to $6.34-$6.46 from $6.22-$6.38; FY2025 revenue guidance raised to $4.99B-$5.02B from $4.89B-$4.94B · full year

The Ensign Group, Inc. — questions

What guidance did The Ensign Group, Inc. give?: On 2026-07-27: "FY2026 EPS guidance raised to $7.75-$7.85 from $7.48-$7.62; revenue raised to $5.87B-$5.92B from $5.81B-$5.86B."
When does The Ensign Group, Inc. report earnings?: The Ensign Group, Inc.'s next earnings report is expected on 2026-11-03.

Every figure on this page comes from The Ensign Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.